Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 28, Issue 3
US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original research
US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics
Online download statistics by month:
Online download statistics by month: March 2023 to September 2024
Abstract
Full
Pdf
Mar 2023
1412
39
21
Apr 2023
468
19
16
May 2023
537
24
19
Jun 2023
345
26
20
Jul 2023
228
17
8
Aug 2023
137
12
7
Sep 2023
124
12
4
Oct 2023
102
6
3
Nov 2023
145
8
3
Dec 2023
143
4
6
Jan 2024
139
7
2
Feb 2024
84
2
0
Mar 2024
78
5
2
Apr 2024
62
2
1
May 2024
90
6
4
Jun 2024
74
0
0
Jul 2024
97
6
7
Aug 2024
64
6
3
Sep 2024
52
1
1
Total
4381
202
127
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF